17120000156826S
AS A CO-INVESTIGATOR, DR. MICHAEL LEWIS WILL ASSIST DR. DANIEL BESWICK (PI) WITH PATIENT ENROLLMENT AND CLINICAL DATA COLLECTION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. LEWIS IS AN EXPERT IN THE FIELD OF PEDIATRIC CYSTIC FIBROSIS. DR. LEWIS WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. AS A COLLABORATOR, DR. PETER NIEDBALSKI WILL ASSIST DR. DANIEL BESWICK (PI) WITH MRI ACQUISITION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. NIEDBALSKI IS AN EXPERT IN THE USE OF MRI FOR PULMONARY IMAGING. HE WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. PARTICIPANT ENROLLMENT WILL FOLLOW THE CRITERIA OUTLINED IN THE DRAFTED STUDY PROTOCOL. PARTICIPANTS WILL COMPLETE QUESTIONNAIRES, OLFACTORY TESTING, SINUS MRI IMAGES, AND QUALITY OF LIFE SURVEYS. PARTICIPANTS FROM THIS SITE WILL BECO-ENROLLED IN THE PARENT STUDY, BEGIN, AND CO-ENROLLED IN THE BEGINNING LOWER AIRWAY MRI STUDY. THE RESEARCH COORDINATOR WILL COLLECT ALL BACKGROUND, SURVEY, IMAGING AND OLFACTORY TESTING DATA, AND ENTER THISDATA UNDER GUIDANCE OF THE PRIMARY SITE FOR CENTRALIZED DATA ENTRY. THIS INDIVIDUAL WILL BE RESPONSIBLE FOR PATIENT ENROLLMENT AND CONSENT PROCEDURES, DATA COLLECTION, PATIENT TRACKING, AND FOLLOW UP AT THE SUB-RECIPIENT SITE. THIS INDIVIDUAL WILL ALSO BE RESPONSIBLE FOR REGULAR, MONTHLY DATA TRANSFERS TO THE PRIMARY SITE. THIS INDIVIDUAL WILL ASSISTWITH IRB REQUIREMENTS FOR SUB-RECIPIENT.
University Of Kansas Medical Center Research Institute, Inc.
Project Grant R01HL174913
$34.3k 12/16/24 17120000156833S
DR. JENNIFER TAYLOR-COUSAR, CO-DIRECTOR OF THE ADULT CYSTIC FIBROSIS PROGRAM AND DIRECTOR OF THE CF THERAPEUTICSDEVELOPMENT CENTER, WILL ASSIST DR. DANIEL BESWICK (PI) AS A CO-INVESTIGATOR WITH OVERALL EXPERIMENTAL DESIGNAND METHODOLOGY, QUALITY ASSURANCE, DATA ANALYSES, AND INTERPRETATION OF RESULTS DURING EACH YEAR OF THIS PROJECTFROM 2024-2029. DR. TAYLOR-COUSAR IS AN EXPERT IN THE FIELD OF CYSTIC FIBROSIS. DR. TAYLOR-COUSAR WILL HAVE VIRTUALMEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD.THE QUANTITATIVE IMAGING LAB (QIL), UNDER THE DIRECTION OF DR. STEPHEN HUMPHRIES WILL OVERSEE THE ANALYSIS OFSINUS MAGNETIC RESONANCE IMAGES (MRI) OBTAINED IN THIS STUDY. THIS INCLUDES SEGMENTING THESE IMAGES TO DEFINETHE PARANASAL SINUS REGION, THE OLFACTORY CLEFT, AND THE OLFACTORY BULB. THE QIL WILL CALCULATE THE PERCENT OF SINUSOPACIFICATION AND OLFACTORY CLEFT OPACIFICATION AND OLFACTORY BULB VOLUME. 220 MRI SCANS ARE PLANNED OVER THESTUDY PERIOD. THE COST FOR ANALYSIS INCLUDES A $7,000 STARTUP FEE, AN IMAGE MANAGEMENT FEE OF $2,000 PER YEARFOR YEARS 1 5, AN IMAGE ANALYSIS FEE OF $180 PER SCAN FOR 220 SCANS, AND A CUSTOMIZATIONS FEE OF $200 PERHOUR, WITH 10 HOURS EACH FOR YEARS 1 5. THE TOTAL IS $66,600.
National Jewish Health
Project Grant R01HL174913
$40.3k 12/4/24 17120000173165S
AS A SITE PI, DR. JASON WOODS WILL ASSIST DR. DANIEL BESWICK (PI) WITH EXPERIMENTAL DESIGN AND METHODOLOGY CENTERED ON SINUS MAGNETIC RESONANCE IMAGING (MRI) SCANS, PATIENT ENROLLMENT, QUALITY ASSURANCE, DATA COLLECTION AND ANALYSES, AND INTERPRETATION OF RESULTS DURING EACH YEAR OF THIS PROJECT FROM2024-2029. DR. WOODS IS AN EXPERT IN THE FIELD IMAGING AND CYSTIC FIBROSIS. DR. WOODS WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD.PARTICIPANT ENROLLMENT WILL FOLLOW THE CRITERIA OUTLINED IN THE DRAFTED STUDY PROTOCOL. PARTICIPANTS WILL COMPLETE QUESTIONNAIRES, OLFACTORY TESTING, SINUS MRI IMAGES, AND QUALITY OF LIFE SURVEYS. PARTICIPANTS FROM THIS SITE WILL BE CO-ENROLLED IN THE PARENT STUDY, BEGIN.THE RESEARCH COORDINATOR WILL COLLECT ALL BACKGROUND, SURVEY, IMAGING AND OLFACTORY TESTING DATA, AND ENTER THIS DATA UNDER GUIDANCE OF THE PRIMARY SITE FOR CENTRALIZED DATA ENTRY. THIS INDIVIDUAL WILL BE RESPONSIBLE FOR PATIENT ENROLLMENT AND CONSENT PROCEDURES, DATA COLLECTION, PATIENT TRACKING, AND FOLLOW UP AT THE SUB-RECIPIENT SITE. THIS INDIVIDUAL WILL ALSO BE RESPONSIBLE FOR REGULAR, MONTHLY DATA TRANSFERS TO THE PRIMARY SITE. THIS INDIVIDUAL WILL ASSIST WITH IRB REQUIREMENTS FOR SUB-RECIPIENT.
Childrens Hospital Medical Center
Project Grant R01HL174913
$74.0k 11/20/24 17120000156841S
AS A CO-INVESTIGATOR, DR. JILL SULLIVAN WILL ASSIST DR. DANIEL BESWICK (PI) WITH PATIENT ENROLLMENT AND DATA COLLECTION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. SULLIVAN IS AN EXPERT IN THE FIELD OF PEDIATRIC CYSTIC FIBROSIS. DR. SULLIVAN WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. AS A COLLABORATOR, DR. BENJAMIN SAWATZKY WILL ASSIST DR. DANIEL BESWICK (PI) WITH MRI DATA COLLECTION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. SAWATZKY IS AN EXPERT IN THE FIELD OF NEUROIMAGING. DR. SAWATZKY WILL HAVEVIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. PARTICIPANT ENROLLMENT WILL FOLLOW THE CRITERIA OUTLINED IN THE DRAFTED STUDY PROTOCOL. PARTICIPANTS WILL COMPLETE QUESTIONNAIRES, OLFACTORY TESTING, SINUS MRI IMAGES, AND QUALITY OF LIFE SURVEYS. PARTICIPANTS FROM THIS SITE WILL BE CO-ENROLLED IN THE PARENT STUDY, BEGIN. THE RESEARCH COORDINATOR WILL COLLECT ALL BACKGROUND, SURVEY, IMAGING AND OLFACTORY TESTING DATA, AND ENTER THIS DATA UNDER GUIDANCE OF THE PRIMARY SITE FOR CENTRALIZED DATA ENTRY. THIS INDIVIDUAL WILL BE RESPONSIBLE FOR PATIENT ENROLLMENT AND CONSENT PROCEDURES, DATA COLLECTION, PATIENT TRACKING, AND FOLLOW UP AT THE SUB-RECIPIENT SITE. THIS INDIVIDUAL WILL ALSO BE RESPONSIBLE FOR REGULAR, MONTHLY DATA TRANSFERS TO THE PRIMARY SITE. THIS INDIVIDUAL WILL ASSIST WITH IRB REQUIREMENTS FOR SUB-RECIPIENT.
University Of Vermont & State Agricultural College
Project Grant R01HL174913
$40.3k 11/1/24 17120000156839S
AS A CO-INVESTIGATOR, DR. JAIME MATA WILL ASSIST DR. DANIEL BESWICK (PI) WITH SINUS MRI ACQUISITION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. MATA IS AN EXPERT IN THE USE OF MRI FOR PULMONARY IMAGING. HE IS PARTICIPATING IN THE BEGINNING TRIAL. DR. MATA WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. AS A COLLABORATOR, DR. DEBORAH FROH WILL ASSIST DR. DANIEL BESWICK (PI) WITH PATIENT ENROLLMENT AND DATA COLLECTION FOR EACH YEAR OF THE STUDY FROM 2024-2029. DR. FROH IS AN EXPERT IN THE FIELD OF PEDIATRIC CYSTIC FIBROSIS. DR. FROH WILL HAVE VIRTUAL MEETINGS WITH DR. BESWICK AT LEAST BIANNUALLY OVER THE STUDY PERIOD. PARTICIPANT ENROLLMENT WILL FOLLOW THE CRITERIA OUTLINED IN THE DRAFTED STUDY PROTOCOL. PARTICIPANTS WILL COMPLETE QUESTIONNAIRES, OLFACTORY TESTING, SINUS MRI IMAGES, AND QUALITY OF LIFE SURVEYS. PARTICIPANTS FROM THIS SITE WILL BE CO-ENROLLED IN THE PARENT STUDY, BEGIN. THE RESEARCH COORDINATOR WILL COLLECT ALL BACKGROUND, SURVEY, IMAGING AND OLFACTORY TESTING DATA, AND ENTER THIS DATA UNDER GUIDANCE OF THE PRIMARY SITE FOR CENTRALIZED DATA ENTRY. THIS INDIVIDUAL WILL BE RESPONSIBLE FOR PATIENT ENROLLMENT AND CONSENT PROCEDURES, DATA COLLECTION, PATIENT TRACKING, AND FOLLOW UP AT THE SUB-RECIPIENT SITE. THIS INDIVIDUAL WILL ALSO BE RESPONSIBLE FOR REGULAR, MONTHLY DATA TRANSFERS TO THE PRIMARY SITE. THIS INDIVIDUAL WILL ASSIST WITH IRB REQUIREMENTS FOR SUB-RECIPIENT.
Rector & Visitors Of The University Of Virginia
Project Grant R01HL174913
$45.5k 10/8/24